Oral treatment of erectile dysfunction: From herbal remedies to designer drugs

Journal of Sex and Marital Therapy

Volumn 24, Issue 2, 1998, Pages 69-73

  Guirguis, Waguih R ^a  

^a St Clement's Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOMORPHINE; BROMOCRIPTINE; DESIGNER DRUG; GLYCERYL TRINITRATE; HERBACEOUS AGENT; NALTREXONE; OXYTOCIN; PHENOXYBENZAMINE; PHENTOLAMINE; SILDENAFIL; TRAZODONE; YOHIMBINE; ZINC;

ARTICLE; DRUG RESEARCH; GINSENG; HUMAN; IMPOTENCE; MALE; ORAL DRUG ADMINISTRATION;

COMPLEMENTARY THERAPIES; ENZYME INHIBITORS; HUMANS; IMPOTENCE; MALE; PHYTOTHERAPY; PIPERAZINES; PLANTS, MEDICINAL;

EID: 0031969959     PISSN: 0092623X     EISSN: 15210715     Source Type: Journal    
DOI: 10.1080/00926239808404920     Document Type: Article

References (16)

1. Lal S, Rios S, Thavundayil JX: Treatment of impotence with Trazodone: A case report. J Urology, 143:819-820, 1990.
2. Susset JG, Tessier CD, Wincze J, Bansal S, Malhotra C, Schwacha MG: Effect of Yohimbine Hydrochloride on erectile impotence: A double-blind study. J Urology, 141:1360-1363, 1989.
3. Wagner G, Brindley GS: The effect of Atropine, a and B-blockers on human penile erection: A controlled pilot study. In A Zorgniotti, G Rossi (eds). Vasculogenic impotence. Springfield, IL: Charles C Thomas, 1980.
4. Ambrosi B, Bara R, Travaglini P, Weber G, Peccoz PB, Rodena M, Elli R, Faglia G: Study of the effects of bromocriptine on sexual impotence. Clin. Endocr., 7: 417-421, 1977.
5. Lidberg L, Sternthal V: A new approach to the hormonal treatment of impotentia erectionis. Pharmakophyschiat Neuropsychopharmako 10: 21, 1977.
6. Mudd JW: Impotence responsive to Glyceryl trinitrate. AmerJPsychiat, 134:922, 1977.
7. Antoniou LD, Shalhoub RJ, Sudhaker T, Smith JC Jr.: Reversal of uraemic impotence by zinc. Lancet, 2: 895, 1977.
8. Gwinup G: Oral Phentolamine in nonspecific erectile insufficiency. Ann Intern Med, 109:162-163, 1988.
9. Lal S, Tesfaye Y, Thavundayil JK, et al: Apomorphine: Clinical studies on erectile impotence and yawning. Neuro-Psychopharmacological and Biological Psychiatry, 13: 329-339, 1989.
10. Fabbri A, Jannini EA, Gnessi L et al: Endorphine in male impotence: Evidence for Naltrexone stimulation of erectile activity in patient therapy. Psychoneuroendocrinology, 14:103-111, 1989.
11. Reid K, Morales A, Harris C, et al: Double-blind trial of Yohimbine in treatment of psychogenic impotence. Lancet, 1: 421-423, 1987.
12. Riley AJ, Goodman RE, Kellett JM et al: Double blind trial of Yohimbine hydrochloride in the treatment of erection inadequacy. Sex Marital Ther, 4: 17-26, 1989.
13. Boolell M, Allen MJ, Ballard SA et al: Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impotence Res, 8: 47-52, 1996.
14. Guirguis WR, Hodges M, Hollingshead M, Dickinson S & Osterloh, I: Sildenafil: A new oral treatment for erectile dysfunction: A 16-week, open-label, dose escalation study. Proceedings of the Royal College of Psychiatrists Meeting, Abstract 12: 82, 1997.
15. Guirguis WR, Hodges M, Hollingshead M & Dickinson, S: Sildenafil: A new oral treatment for erectile dysfunction: An eight-week double-blind, placebo-controlled parallel group study. Proceedings of the American Psychiatric Association Annual Meeting, Abstract 37: 16, 1997.
16. Buvat J, Gingell CJ, Jardin A et al: Sildenafil (Viagra), an oral treatment for erectile dysfunction: A one year, open-label extention study. Proceedings of the American Urological Association, Abstract 793: 204, 1997.